ArticleFrontiers in endocrinology2025

Pre-existing subclinical hypothyroidism and low free thyroxine in patients undergoing immune checkpoint inhibitor therapies is a risk factor for overt hypothyroidism.

Yu Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.